1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NHMRC-Horizon Europe 2025 is a grant from the National Health and Medical Research Council (NHMRC) that funds collaborative health and medical research projects between Australian researchers and their counterparts in Horizon Europe member countries. The program supports international collaborative research on health priorities of shared interest, strengthening ties between Australia and the European research community.
The application deadline was April 29, 2026. Eligible applicants are researchers based in Australia and Horizon Europe member countries working together on joint projects.
Get alerted about grants like this
Save a search for “National Health and Medical Research Council (NHMRC)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
# NHMRC-Horizon Europe 2025 | NHMRC * Health adviceOpen submenu * Research policyOpen submenu * Manage your fundingOpen submenu * NHMRC grant programOpen submenu * Medical Research Future Fund * International collaborative fundingOpen submenu * Targeted Calls for Research * Outcomes and data on researchOpen submenu * Working together to support research Close submenuManage your funding * NHMRC FundingOpen submenu * MRFF FundingOpen submenu Close submenuNHMRC Funding * Funding agreement and deed of agreement * Administering InstitutionsOpen submenu * Direct Research Cost Guidelines * Personnel and Salary Support PackagesOpen submenu Close submenuAdministering Institutions * Institutional Annual Compliance Report * Progress, final and additional reporting Close submenuPersonnel and Salary Support Packages * Previous Personnel Support Package rates * Previous Salary Support Package rates Close submenuMRFF Funding * MRFF Eligible OrganisationsOpen submenu * Reporting and milestonesOpen submenu * Direct Research Costs and Personnel and Salary Support Packages Close submenuMRFF Eligible Organisations * Institutional approvals and grant conditions Close submenuReporting and milestones * Scientific reporting and milestones Close submenuNHMRC grant program * NHMRC grant program schemes Close submenuInternational collaborative funding * International engagement strategy and activities * International collaborative health research funding * Other opportunities for international collaboration Close submenuOutcomes and data on research * Outcomes of funding rounds Close submenuHealth advice * Aboriginal and Torres Strait Islander health * Children’s health and development * Environmental healthOpen submenu * Public healthOpen submenu * Guidelines for Guidelines Close submenuEnvironmental health * Water quality and health Close submenuPublic health * Health effects of water fluoridation * Complementary medicines Close submenuResearch policy * Consumer and community involvementOpen submenu * Embryo research licensingOpen submenu * International engagement * Gender equityOpen submenu * Research prioritiesOpen submenu Close submenuConsumer and community involvement * Consumer and community engagement * Completed consultation activities * Consumer and community representative involvement in the peer review process * Review of the Statement on Consumer and Community Involvement Close submenuEmbryo research licensing * Commonwealth and State Legislation * Information for applicants * Information for Licence Holders * Embryo Research Licensing Committee reports to parliament * Import and export of cell lines * Database of Licences issued * Training and Quality Assurance * National Statement on Ethical Conduct in Human Research * Ethical guidelines for research with Aboriginal and Torres Strait Islander Peoples * Ethical guidelines for Assisted Reproductive Technology * Ethical guidelines for cell, tissue and organ donation and transplantation * Guide for assessing research involving AI * Human research ethics committees * National Certification Scheme * The Human Research Ethics Applications (HREA) * Ethical issues and further resources Close submenuGender equity * NHMRC Gender Equity Strategy * Structural priority funding and gender equity * Administering Institutions – consideration of gender equity * Statement on Sex and Gender in Research * Sex, gender, variations of sex characteristics and sexual orientation in the grant program Close submenuResearch priorities * Community research priorities portal * NHMRC health priorities 2024–2027 * Regional, Rural and Remote Health Equity * Framework for Identifying and Prioritising Targeted Calls for Research * Targeted Calls for Research Prioritisation Criteria Rubric * Guide for Proposing Targeted Calls for Research * Leadership and governanceOpen submenu * Publications and resourcesOpen submenu * NHMRC AwardsOpen submenu * Accountability and reporting Close submenuLeadership and governance * Legislative basis to NHMRC * Senior executive and leadership team Close submenuPublications and resources * Annual reports and corporate plans Close submenuNHMRC Awards * Research Excellence Awards * Temporary Employment Register * How we select our people * Indigenous internship program [](https://www.
nhmrc. gov.au/ "Home") * Outcomes of funding rounds [](https://www. nhmrc.
gov.au/funding/find-funding/nhmrc-eu-collaborative-research-grant-scheme-2025#off-canvas "Menu") * Medical Research Future Fund * International collaborative funding * Targeted Calls for Research * Outcomes and data on research * Working together to support research Research funding statistics and data * Aboriginal and Torres Strait Islander health * Children’s health and development * Guidelines for Guidelines Guidelines for Guidelines * Consumer and community involvement * Embryo research licensing * International engagement Embryo research licensing * Leadership and governance * Publications and resources * Accountability and reporting 3.
NHMRC-Horizon Europe 2025 # NHMRC-Horizon Europe 2025 [](https://www. nhmrc. gov.au/funding/find-funding/nhmrc-eu-collaborative-research-grant-scheme-2025) The National Health and Medical Research Council (NHMRC) – Horizon Europe Grant Scheme supports Australian participation in leading international collaborative research under Horizon Europe, which is the European Union's (EU) key funding program for research and innovation.
Horizon Europe facilitates collaboration and strengthens the impact of research and innovation while tackling global challenges. It supports the creation and better dispersion of excellent knowledge and technologies.
NHMRC selects topics that align with the health priorities identified in the NHMRC Corporate Plan, and are guided by the principles of the NHMRC’s International Engagement Strategy 2023–2026 to support collaborative approaches to health and medical research internationally. The following topics are being supported by NHMRC for the 2025 NHMRC-Horizon Europe grant opportunity.
NHMRC will invite Australian-based researchers who are listed on eligible applications deemed fundable by the European Commission to apply to NHMRC for support of the Australian component of research under the following topics submitted through the **single-stage deadline model:** * HORIZON-HLTH-2025-01-DISEASE-01: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections * HORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential * HORIZON-HLTH-2025-01-DISEASE-04: Leveraging artificial intelligence for pandemic preparedness and response * HORIZON-HLTH-2025-01-DISEASE-07: Tackling high-burden for patients and under-researched medical condition * HORIZON-HLTH-2025-01-TOOL-01: Enhancing cell therapies with genomic techniques * HORIZON-HLTH-2025-01-TOOL-02: Advancing cell secretome-based therapies * HORIZON-HLTH-2025-01-TOOL-05: Boosting the translation of biotech research into innovative health therapies * HORIZON-HLTH-2025-01-IND-01: Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs) * HORIZON-HLTH-2025-01-IND-02: Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices and submitted through the **two-stage deadline model:** * HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage: Improving the quality of life of persons with intellectual disabilities and their families * HORIZON-HLTH-2025-03-ENVHLTH-01-two-stage: The impact of pollution on the development and progression of brain diseases and disorders * HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage: Advancing knowledge on the impacts of micro- and nanoplastics on human health * HORIZON-HLTH-2025-03-DISEASE-02-two-stage: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders * HORIZON-HLTH-2025-03-IND-03-two-stage: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative ('breakthrough') devices.
Further information about Horizon Europe topics can be found on the European Commission’s webpage.
* European Commission invites submissions against advertised research topics * European Commission conducts peer review * European Commission advises NHMRC Administering Institution/s of favourable evaluations * NHMRC Administering Institution/s notify NHMRC of applicant details * NHMRC will invite Australian researchers who are listed on eligible applications deemed fundable by the European Commission to apply to NHMRC for support of the Australian component of research by submitting an application in Sapphire * NHMRC reviews the budget requested for the Australian components of the research * Funding recommendations approval process.
The NHMRC-Horizon Europe scheme has eligibility criteria and applications will be excluded from consideration if eligibility requirements are not met: * Australian applicants must be listed on eligible applications deemed fundable by the European Commission * The Administering Institution for the NHMRC- Horizon Europe scheme application must be listed as an Associated Partner in the EU application * Evidence, such as the EU grant agreement or a letter from the EU, which indicates that the relevant EU application has been evaluated favourably and will proceed to the preparation of the grant agreement * Applications must be under the selected topics as listed by NHMRC.
Before you submit an application, please make sure you have: ### Grant submission advice Read all relevant reference material GrantConnect GO Documents ### Liaise with your Administering Institution to identify any specific requirements that the institution may have ### Ensure your application is complete and correct.
_Close: 16 September 2025_ _Stage one open: 22 May 2025_ _Stage one close: 16 September 2025_ _Stage two open: January 2026_ _Stage two close: 16 April 2026_ **Sapphire applications** _Close: 25 November 2026_ You will need to use Sapphire to access or enter your CV and profile, and submit your application. Sapphire has training material to help with system tasks. Applications for grants can be made by registering.
RAOs have been contacted directly with instructions on how to establish an RAO account. If you have any questions please contact theResearch Help Centre. ## Contact research admin office If you need more information, contact your Research Administration Office in the first instance.
If you need help and are unable to satisfy your concern through your Administering Institution (or MRFF Eligible Organisation), contact the Research Help Centre. Go to the National Health and Medical Research Council home page | Australian Government NHMRC acknowledges the Traditional Custodians of the lands around Australia and pays our respect to their Elders, both past and present.
**Your feedback matters** We're always looking for ways to improve our site. * Connect with the National Health and Medical Research Council on Facebook * Connect with the National Health and Medical Research Council on Twitter * Connect with the National Health and Medical Research Council on LinkedIn * Connect with the National Health and Medical Research Council on Instagram
Based on current listing details, eligibility includes: Researchers in Australia and Horizon Europe member countries. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is April 29, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
AAI Career Awards is a grant from the American Association of Immunologists (AAI) that honors members for outstanding research and career achievement. Through multiple award tracks — including the Lifetime Achievement Award, Distinguished Service Award, Distinguished Fellows program, Public Service Award, and Vanguard Award — AAI recognizes immunologists at every career stage who have made exceptional scientific, institutional, or public-policy contributions. Nominations originate from the AAI Council and designated committees. The program celebrates careers defined by scientific excellence, service to the immunology community, and contributions to public advocacy, minority recruitment in the sciences, and disease research. Deadline is September 10, 2025.